Adaptive Trial Demand Berry Consultants specializes in adaptive trial design and Bayesian analysis, with software solutions like ADDPLAN and FACTS that enable complex, multi-arm, platform trials. This positions them to capitalize on growing pharma and device client interest in flexible, efficient trial designs and robust simulations.

Software Leadership The company develops and licenses its own simulation and planning tools (QUOTES, ADDPLAN, FACTS), signaling recurring revenue opportunities through SaaS-like offerings and potential upsell of additional modules or advanced features to existing customers.

Strategic Partnerships Berry has active engagement with sponsors, regulatory agencies, and international funders (FDA, EMA, NIH, PCORI, and global government research bodies), suggesting partnerships with larger organizations for continued consulting work, platform trials, and joint studies.

Industry Momentum Evidence of recent market activity includes a notable partnership with PharmAust and the launch of FACTS 7, indicating ongoing product refinement and demand for cutting-edge trial simulation capabilities among biotech and pharmaceutical clients.

Global Reach Berry's experience across multiple jurisdictions and international trial implementations, plus a diverse client base supported by global funders, suggests opportunity to expand into new regions or vertically integrate services for multinational trials and regulatory submissions.